Lygenesis

LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient's own lymph nodes into bioreactors capable of growing functioning ectopic organs. Its allogeneic cell therapies target some of the largest unmet needs in medicine, from Type 1 diabetes to end-stage liver and renal disease, upending the economics of organ transplantation since one donated liver can be used to treat dozens of patients via an outpatient endoscopic ultrasound procedure.